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Supplement Aims and Scope
Spatio-Temporal Simulation Models§§
Parametric Validation of Simulation Models§§
Simulation of Dynamic Phenomena in Cancer using §§
Highly Specialized Algorithms
Hyper-High Performance and Biocomplexity Systems §§
Modelling of Cancer
Sequence Alignment Methods for DNA-Seq, RNA-§§
Seq, miRNA-Seq, CHiP-Seq Experiments
Spectra Analysis §§
Generic Visualization Tools§§
Array-Comparative Genomic Hybridization §§
Visualization
Statistical Methods for Next Generation Sequencing §§
Data
Predictive Modeling for High-Dimensional Data§§
Robust Feature Selection §§
Integration and Analysis of Big Biomedical Data§§
Meta-Data Imaging§§
Equivalent Cross-Relaxation Imaging§§
Mathematical Modeling and Image Enhancement of §§
MRI Cancer Data
Rapid Imaging Analysis of PET Cancer Scans§§
Cancer Informatics represents a hybrid discipline encompass-
ing the fields of oncology, computer science, bioinformat-
ics, statistics, computational biology, genomics, proteomics, 
metabolomics, pharmacology, and quantitative epidemiology. 
The common bond or challenge that unifies the various dis-
ciplines is the need to bring order to the massive amounts of 
data generated by researchers and clinicians attempting to find 
the underlying causes and effective means of treating cancer.
The future cancer informatician will need to be well-versed 
in each of these fields and have the appropriate background 
to leverage the computational, clinical, and basic science 
resources necessary to understand their data and separate 
signal from noise. Knowledge of and the communication 
among these specialty disciplines, acting in unison, will be 
the key to success as we strive to find answers underlying the 
complex and often puzzling diseases known as cancer.
Articles focus on computer simulation, bioinformatics, 
and statistical analysis of cancer data and processes and 
may include:
Multi-dimensional Simulation Models of Tumour §§
Response
Simulating Tumour Growth Dynamics§§
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Cancer is a widely-recognized public health burden and a complex disease. High-dimensional “Omics” research – research that uses high dimensional genomic, pro-
teomic, and/or metabolomic data – has often been motivated 
by cancer applications1. Important lessons have been learned 
in processing and analyzing such data. Further, additional 
sophisticated technologies in medical imaging, geographic 
information systems, and environmental exposure monitor-
ing also give rise to high-dimensional data. Yet, as quickly as 
methods adapt to the new technologies, it seems that biotech-
nological developments produce even higher dimensional and 
more complex datasets – making bioinformatics more and 
more critical to the processing and understanding of patient 
data. But, in the rush of data processing we must not lose 
sight of biostatistics principles so that data are correctly inter-
preted, signal separated from noise, and new discoveries effi-
ciently translated into clinical practice without unnecessary 
delays or inefficiencies. This supplement includes articles by 
various researchers in statistics, biostatistics and bioinformat-
ics who are developing methods for addressing a wide spec-
trum of scientific questions related to big data. Some of these 
main areas are summarized below.
As mentioned, the challenges facing today in cancer 
informatics are multifaceted lying at the interface of bioinfor-
matics, genetic epidemiology, epigenetics, and risk prediction, 
and several authors contributed in these areas. In particular, 
some papers focused on the approaches for detecting gene-gene 
and gene-environment interactions. Talluri and Shete consid-
ered an information theory approach for detecting epistasis, 
compared it with a standard logistic regression approach, and 
demonstrated utility by applying it to head and neck cancer 
data. Liu and Xuan constructed a mutual SNP association 
network (SAN) based on information from various sources of 
gene interaction such as protein-protein interaction and gene 
co-expression, with the goal that SAN reflects the real func-
tional associations between genomic loci. Zhang and Biswas 
focused on detecting interactions of rare haplotypes with envi-
ronmental covariates with an enhanced version of Logistic 
Bayesian LASSO and used it to uncover a rare haplotype 
interaction with smoking for lung cancer. Zang et al. conside-
red lung cancer and explored the association of its sub-types 
with CDKN3 gene expression, and found that higher expres-
sion of CDKN3 was associated with poorer survival outcomes 
for lung adenocarcinoma but not for squamous cell carcinoma. 
Sun and Li developed a pipeline to identify hemi-methylation, 
that is, DNA methylation occurring in one strand only, and 
characterized different patterns in the entire genome, and 
applied the method to breast cancer cell lines. Mazzola et al. 
reviewed many recent enhanced capabilities of the widely used 
breast cancer genetic risk prediction model BRCAPRO that 
estimates the probability that a counselee carries mutations of 
BRCA1 or BRCA2 genes given her family history. 
Other papers focused on extensions and applications 
of penalized or regularized models, such as the LASSO. 
Zemmour et al. took an important look back at centrally 
important breast cancer datasets. These datasets had previ-
ously been used to develop bioinformatic diagnostic tools that 
are currently in use. But these tools were developed when we 
knew less about the statistics of this type of data than we do 
today. They applied regularized methods that are becoming the 
gold standard in this area. They found that shorter and argu-
ably more robust gene lists with equivalent prediction value 
are the result. They also found that the overlap of the gene 
lists from different modern tools is much higher than with the 
previous tools, suggesting that the previous poor overlap may 
have caused unnecessary concerns. Other articles pertained to 
extending penalized methods for discrete response modeling. 
For example, ordinal responses have an inherent ordering, but 
the distance between the responses cannot be quantitatively 
measured. Examples of ordinal variables include tumor grade 
(T0 to T4), degree of spread to the lymph nodes (N0 to N3), 
and cancer stage (I to IV), all of which are commonly reported 
in cancer research studies. The ordinal generalized monotone 
incremental forward stagewise method (GMIFS) was previ-
ously described for fitting ordinal response models in the pres-
ence of a high-dimensional covariate space. Ferber and Archer 
demonstrated how the GMIFS algorithm, via a forward con-
tinuation ratio model, could be used to fit a discrete survival 
time response model, applicable when survival is recorded on 
an ordinal scale such as short-, intermediate-, and long-term 
survival. Gentry et al extended the ordinal GMIFS algorithm 
to enable inclusion of covariates that should not be penalized 
in the model fitting process, and applied the method to predict 
stage of breast cancer using methylation of high-throughput 
CpG sites as penalized predictors with important clinical 
covariates coerced into the model. Makowski and Archer 
extended the GMIFS method to the Poisson regression setting 
for modeling a count response in high-dimensional covariate 
spaces, and applied the method for predicting micronuclei fre-
quency using gene expression features as predictors. 
In order to understand the gene regulatory mechanism 
in cancer, Wei P et al. proposed a novel statistical framework 
to integrate diverse types of genomic data from The Cancer 
Genome Atlas (TCGA) to decipher expression regulation. 
Wei Y et al. tackled a similar problem and proposed joint 
models for integrative analysis of multiple types of omics data. 
The results from the analysis shed light on personalized medi-
cine. Statistical methods for differential expression analysis 
in both microarray and RNA-seq have been well-developed, 
however, the method for equivalent expression analysis is 
still seriously lacking. Cui et al. proposed a novel statistical 
method to test equivalent expressions among multiple treat-
ment groups. Zhou et al. compared the traditional approach 
of univariate modeling to linear mixed effects modeling when 
assessing the relationship between psychoneurological symp-
toms (anxiety, depression, and stress) and methylation of CpG 
sites. O’Donnell et al. examined the exciting and emerging 
area of immunology signatures in cancer. Their goal was to 
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investigate the potential for development of an early detec-
tion and diagnostic tool that can be used on a simple blood 
draw. Their intriguing approach uses a peptide microarray and 
a time-frequency analysis. Zhao et al. reported on the develo-
pment of informatics for a precision oncology – personal-
ized medicine – clinical trial. The molecular profiling-based 
assignment of cancer therapy trial (MPACT) uses genomic 
profiling in novel ways to determine patient treatment. It is 
one of the first in what is likely to be a long line of such trials, 
and they describe how complex molecular characterization 
of the patients can be folded into clinical trial randomization 
and quality control. They show that careful development of 
bioinformatics tools can facilitate optimal interactions among 
diverse multidisciplinary teams composed of clinicians, 
molecular oncologists, statisticians and bioinformaticians. 
Some articles pertained to analyzing the spatial dimen-
sion in cancer. A catchment area is the geographic area and 
population from which a cancer center draws patients, and 
defining a catchment area allows a cancer center to describe 
its primary patient population and assess how well it meets 
the needs of cancer patients. Wang and Wheeler estimated 
diagnosis and treatment catchment areas for the Massey Can-
cer Center at Virginia Commonwealth University using can-
cer registry and patient billing data and Bayesian hierarchical 
regression models. Historically, generalized additive models 
with bivariate smoothing functions have been applied to esti-
mate spatial variation in cancer risk. Siangphoe and Wheeler 
evaluated the ability of different smoothing functions in genera-
lized additive models to detect overall spatial variation of risk 
and elevated risk in diverse geographical areas using a simula-
tion study. 
Another aspect of spatial dimension in cancer is the het-
erogeneity within each tumor, especially in regard to changes 
over time. Diffusion tensor imaging provides a way to image 
brain tumors. To assess changes over time from treatment and 
tumor growth, it is necessary to register serial images against 
a high-quality reference of pure brain tissue. This allows 
comprehensive visualization of the entire tumor progression 
through the course of treatment. Ceschin et al provide an open 
source pipeline, sfDM (serial functional diffusion mapping), 
for registering and processing the images. They also evalu-
ate different registration methods. Hobbs and Ng are con-
cerned with monitoring tumor characteristics via perfusion 
imaging, and describe a model-based approach for inferring 
stability for stochastic curve estimation, a useful statistically- 
based technique.
Other articles described methods for assessing environ-
mental chemical exposures. Environmental variables used in 
regression models to explain environmental chemical expo-
sures or cancer outcomes are typically modeled at the same 
spatial scale. Grant, Gennings, and Wheeler presented four 
model selection algorithms that select the best spatial scale 
for each area-based covariate to explain variation in ground-
water nitrate concentrations in Iowa. In the evaluation of 
cancer risk related to environmental chemical exposures, the 
effect of many chemicals on disease is ultimately of interest. 
The method of weighted quantile sum (WQS) regression 
attempts to overcome these problems by estimating a body 
burden index that identifies important chemicals in a mixture 
of correlated environmental chemicals. Czarnota, Gennings, 
and Wheeler assessed through simulation studies the accuracy 
of WQS regression in detecting subsets of chemicals associ-
ated with health outcomes and found that WQS regression 
had good sensitivity and specificity across a variety of con-
ditions. The relationship between correlated environmental 
chemicals and health effects was not always constant across a 
study area, as exposure levels may change spatially due to vari-
ous environmental factors. Czarnota, Wheeler, and Gennings 
assess through a simulation study the ability of geographically 
weighted regression (GWR) and geographically weighted 
lasso (GWL) to correctly identify spatially varying chemical 
effects for a mixture of correlated chemicals within a study 
area and find that GWR suffered from the reversal paradox, 
while GWL over-penalized the effects for the chemical most 
strongly related to the outcome.
A promising approach to cancer treatment leverages new 
understanding of the role of cancer stem cells (CSCs) and dis-
covery of agents targeting them. Day uses tumor dynamics 
modeling to illustrate two special challenges in CSC-targeted 
treatment: how to design combination regimens that stand the 
best chance of success, and how to design clinical trials with 
time frames and endpoints sufficient to detect highly success-
ful regimens that otherwise would be missed.
RefeRence
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